BLO Cannabix Technologies Inc

Cannabix Technologies announces Stock Option Grant

Cannabix Technologies announces Stock Option Grant

VANCOUVER, British Columbia, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) reports it has granted 2,500,000 incentive stock options (“the Options”) to certain directors and consultants of the Company, exercisable at $0.55. 700,000 of the Options will expire in five years from the date of grant, 800,000 will expire in two years (subject to vesting provisions) from the date of grant and 1,000,000 will expire after 1 year from the date of grant. The Options, and any underlying common shares issued on exercise thereof, will have a hold period expiring 4 months and one day, in accordance with the policies of the CSE and applicable securities laws. The Options are subject to the terms and conditions of the Company's stock option plan and the policies of the CSE.

We seek Safe Harbor.

On behalf of the Board of Directors

“Rav Mlait”

CEO

Cannabix Technologies Inc.

For further information, contact the Company at

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.



EN
23/10/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cannabix Technologies Inc

 PRESS RELEASE

Cannabix Technologies Launches New Marijuana Breath Test Product Video...

Cannabix Technologies Launches New Marijuana Breath Test Product Videos as U.S. Cannabis Reclassification Underscores the Urgent Need for Innovative Public Safety Solutions VANCOUVER, British Columbia, Dec. 19, 2025 (GLOBE NEWSWIRE) --  Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to announce that it has launched new product videos showcasing the Company’s Marijuana Breath Test (MBT) solution (Figures 1 and 2). These videos highlight the MBT’s advanced features and benefits, i...

 PRESS RELEASE

Cannabix Marijuana Breath Test Clears Key Regulatory Milestone: Handhe...

Cannabix Marijuana Breath Test Clears Key Regulatory Milestone: Handheld Breath Collection Unit (BCU) Passes FCC Electronic Emissions Testing VANCOUVER, British Columbia, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to announce that the Cannabix Breath Collection Unit (BCU) has successfully passed electronic emissions testing required by the Federal Communications Commission (FCC). The handheld BCU (Figures 1 and 2) along with Cannabix’s proprietary Breath Cartridges, forms the core hardware ...

 PRESS RELEASE

Cannabix Technologies Strengthens Presence in Maritime Market with Rep...

Cannabix Technologies Strengthens Presence in Maritime Market with Repeat BreathLogix Alcohol Screening Device Order VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to announce that it has entered into a second sales agreement for its BreathLogix unmanned alcohol screening technology with an existing European maritime shipping customer. Under this agreement, the Company will deliver an additional BreathLogix unit to e...

 PRESS RELEASE

Cannabix Technologies announces Non-Brokered LIFE Private Placement

Cannabix Technologies announces Non-Brokered LIFE Private Placement NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES ORFOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (the “Company or Cannabix”) announces a non-brokered private placement for a minimum of 2,127,659 units (the "Units") of the Company at a price of C$0.47 per Unit for aggregate gross proceeds to the Company of $1,000,000 and up to a maximum of 4,255,319 Units for aggregate gross proceeds of $2,000,000 (the "Offering"). The O...

 PRESS RELEASE

Cannabix Technologies Granted Patent from USPTO for Contactless Breath...

Cannabix Technologies Granted Patent from USPTO for Contactless Breath Analysis VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to report that the United States Patent and Trademark Office (USPTO) has granted patent No. 18/1729,658 entitled, “Contact-Free Breath Analysis Device and Method” to the Company. This patent is centered on innovations made by Cannabix and its dual mode contactless (and traditional mouthpiece) breath capture and analysis technology used...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch